FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,535,459 | -29.9% | 724,273 | +57.4% | 0.00% | -100.0% |
Q2 2023 | $2,190,942 | +304.5% | 460,282 | +384.4% | 0.00% | – |
Q1 2023 | $541,660 | -65.4% | 95,028 | -38.7% | 0.00% | -100.0% |
Q4 2022 | $1,563,416 | +485.5% | 154,947 | +1199.5% | 0.00% | – |
Q3 2022 | $267,000 | -51.5% | 11,924 | -46.3% | 0.00% | – |
Q2 2022 | $550,000 | -59.7% | 22,195 | -36.9% | 0.00% | – |
Q1 2022 | $1,365,000 | -78.5% | 35,200 | -67.5% | 0.00% | -100.0% |
Q4 2021 | $6,338,000 | +244.3% | 108,335 | +248.7% | 0.00% | – |
Q3 2021 | $1,841,000 | -35.3% | 31,064 | -5.2% | 0.00% | -100.0% |
Q2 2021 | $2,845,000 | -39.6% | 32,776 | -42.7% | 0.00% | -50.0% |
Q1 2021 | $4,714,000 | -22.4% | 57,174 | -14.4% | 0.00% | -33.3% |
Q4 2020 | $6,073,000 | +248.6% | 66,788 | +53.3% | 0.00% | +200.0% |
Q3 2020 | $1,742,000 | +200.9% | 43,575 | +158.1% | 0.00% | – |
Q2 2020 | $579,000 | +135.4% | 16,882 | +52.5% | 0.00% | – |
Q1 2020 | $246,000 | +1.7% | 11,071 | -28.9% | 0.00% | – |
Q3 2019 | $242,000 | -21.7% | 15,562 | +2.1% | 0.00% | -100.0% |
Q2 2019 | $309,000 | +76.6% | 15,242 | +11.6% | 0.00% | – |
Q4 2018 | $175,000 | +6.1% | 13,656 | +34.8% | 0.00% | – |
Q3 2018 | $165,000 | +42.2% | 10,127 | -0.8% | 0.00% | – |
Q2 2018 | $116,000 | +157.8% | 10,213 | -9.6% | 0.00% | – |
Q3 2017 | $45,000 | -41.6% | 11,292 | -7.4% | 0.00% | -100.0% |
Q2 2014 | $77,000 | -33.6% | 12,200 | +2.5% | 0.00% | 0.0% |
Q1 2014 | $116,000 | – | 11,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |